Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt

Modify Date: 2025-08-25 20:50:20

Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt Structure
Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt structure
Common Name Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt
CAS Number 64790-15-4 Molecular Weight 1352.51000
Density 1.339 g/cm3 Boiling Point 1828.5ºC at 760 mmHg
Molecular Formula C61H89N15O18S Melting Point N/A
MSDS N/A Flash Point 1059.6ºC

 Use of Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt


Glucagon (19-29), human is a potent and efficient inhibitor of insulin secretion.

 Names

Name h-ala-gln-asp-phe-val-gln-trp-leu-met-asn-thr-oh
Synonym More Synonyms

  Biological Activity

Description Glucagon (19-29), human is a potent and efficient inhibitor of insulin secretion.
Related Catalog
Target

Insulin secretion[1]

In Vitro Glucagon (19-29), from 0.1 pM to 1 nM, exerts a potent negative inotropic action. The most striking observation is a 45% increase in the amplitude of cell contractility elicited by the combination of 30 nM glucagon with 1 nM Glucagon (19-29)[3].
In Vivo Glucagon (19-29), also named Miniglucagon, is the COOH-terminal (19-29) fragment processed from glucagon. Glucagon (19-29) dose-dependently inhibits insulin secretion stimulated by 8.3 M glucose, with no change in the perfusion flow rate. A concentration of 1 nM Glucagon (19-29) has a significant inhibitory effect on a 1 nM glucagon-like peptide 1 (7-36) amide–potentiated insulin secretion[1]. Glucagon (19-29) is a highly potent and efficient inhibitor of insulin release by closing, via hyperpolarization, voltage-dependent Ca2+ channels linked to a pathway involving a pertussis toxin-sensitive G protein[2].
Animal Admin Rats[1] To test the effect of miniglucagon (Glucagon (19-29)) on stimulated insulin secretion, 8.3 mM glucose is perfused during the experiments, including a 45-min equilibration period, followed by miniglucagon (1, 10, 100, and 1,000 pM) perfused with or without 1 nM tGLP-1. To study the glucagon and miniglucagon secretion, the glucose concentration is switched from 11 to 3 mM after a 45-min stabilization period, and the peptides secreted are measured by radioimmunoassay[1].
References

[1]. Dalle S, et al. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. J Biol Chem. 1999 Apr 16;274(16):10869-76.

[2]. Dalle S, et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. Diabetes. 2002 Feb;51(2):406-12.

[3]. Pavoine C, et al. Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagon. Am J Physiol. 1991 May;260(5 Pt 1):C993-9.

 Chemical & Physical Properties

Density 1.339 g/cm3
Boiling Point 1828.5ºC at 760 mmHg
Molecular Formula C61H89N15O18S
Molecular Weight 1352.51000
Flash Point 1059.6ºC
Exact Mass 1351.62000
PSA 582.21000
LogP 2.66020
Index of Refraction 1.596
InChIKey SVHJFTNFNMWDBS-FPLSMPAJSA-N
SMILES CSCCC(NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CCC(N)=O)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(CC(=O)O)NC(=O)C(CCC(N)=O)NC(=O)C(C)N)C(C)C)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)O)C(C)O

 Synonyms

Miniglucagon (huMan,rat,porcine)
Glucagon (19-29) (human,rat,porcine)
GLUCAGON (19-29),HUMAN
AQDFVQWLMNT
glucagon(19-29
Glucagon (19-29) (huMan,rat,porcine) Miniglucagon (huMan,rat,porcine)
ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR
GLUCAGON (19-29),BOVINE,HUMAN,PORCINE
GLUCAGON (19-29) (HUMAN,BOVINE,PORCINE)
Glucagon (19-29), human
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt suppliers


Price: $60/5mg

Reference only. check more Glucagon (19-29) (human, rat, porcine) trifluoroacetate salt price